File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Catechol-O-methyltransferase inhibitors in Parkinson's disease (multiple letters) [9]

TitleCatechol-O-methyltransferase inhibitors in Parkinson's disease (multiple letters) [9]
Authors
Henry, CWilson, JAXie, THo, SLRamsden, D
Issue Date1998
PublisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/lancet
Citation
Lancet, 1998, v. 351 n. 9120, p. 1965-1966 How to Cite?
DOI: http://dx.doi.org/10.1016/S0140-6736(05)78659-1
Persistent Identifierhttp://hdl.handle.net/10722/162269
ISSN
0140-6736
2023 Impact Factor: 98.4
2023 SCImago Journal Rankings: 12.113
ISI Accession Number ID
WOS:000074464700066

 

DC FieldValueLanguage
dc.contributor.authorHenry, Cen_US
dc.contributor.authorWilson, JAen_US
dc.contributor.authorXie, Ten_US
dc.contributor.authorHo, SLen_US
dc.contributor.authorRamsden, Den_US
dc.date.accessioned2012-09-05T05:18:31Z-
dc.date.available2012-09-05T05:18:31Z-
dc.date.issued1998en_US
dc.identifier.citationLancet, 1998, v. 351 n. 9120, p. 1965-1966en_US
dc.identifier.issn0140-6736en_US
dc.identifier.urihttp://hdl.handle.net/10722/162269-
dc.languageengen_US
dc.publisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/lanceten_US
dc.relation.ispartofLanceten_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 And Overen_US
dc.subject.meshAntiparkinson Agents - Adverse Effects - Therapeutic Useen_US
dc.subject.meshBenzophenones - Adverse Effects - Therapeutic Useen_US
dc.subject.meshCatechol O-Methyltransferase - Antagonists & Inhibitorsen_US
dc.subject.meshConfusion - Chemically Induceden_US
dc.subject.meshDrug Administration Scheduleen_US
dc.subject.meshEnzyme Inhibitors - Adverse Effects - Therapeutic Useen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshNitrophenolsen_US
dc.subject.meshParkinson Disease - Drug Therapyen_US
dc.titleCatechol-O-methyltransferase inhibitors in Parkinson's disease (multiple letters) [9]en_US
dc.typeArticleen_US
dc.identifier.emailHo, SL:slho@hku.hken_US
dc.identifier.authorityHo, SL=rp00240en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/S0140-6736(05)78659-1-
dc.identifier.pmid9654299-
dc.identifier.scopuseid_2-s2.0-0032572312en_US
dc.identifier.volume351en_US
dc.identifier.issue9120en_US
dc.identifier.spage1965en_US
dc.identifier.epage1966en_US
dc.identifier.isiWOS:000074464700066-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridHenry, C=19334669300en_US
dc.identifier.scopusauthoridWilson, JA=8934522900en_US
dc.identifier.scopusauthoridXie, T=7103076362en_US
dc.identifier.scopusauthoridHo, SL=25959633500en_US
dc.identifier.scopusauthoridRamsden, D=7102612805en_US
dc.identifier.issnl0140-6736-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats